20
4/2/2021 1 Breast Ultrasound INDICATIONS NORMAL ANATOMY TECHNIQUE Annina N. Wilkes MD Thomas Jefferson University Hospital Palpable mass/thickening Focal Pain Nipple discharge Women under 30, targeted ultrasound is the first study, mammography as needed Women over 30, bilateral mammogram is the first study, targeted ultrasound to follow INDICATIONS Symptoms INDICATIONS Abnormal Mammogram Mass Developing asymmetry/focal asymmetry Architectural distortion Calcifications INDICATIONS Abnormal Imaging MRI Nuclear medicine CAT Scan Contrast Enhanced Mammography (CEM) Other INDICATIONS Follow up Probably benign masses (BIRADS 3) – 6 month f/u to assess for stability/2 year Abscess following antibiotic therapy Hematoma/seroma Trauma - bruise INDICATIONS Known or Suspected Malignancy (BIRADS 4,5,6) Determination of extent, multifocality Evaluation of axillary lymph nodes Monitoring response to neoadjuvant chemotherapy – breast, axilla and chest wall Screening chest wall lymph nodes after therapy

Breast Ultrasound - Thomas Jefferson University

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

4/2/2021

1

Breast UltrasoundINDICATIONS

NORMAL ANATOMY

TECHNIQUE

Annina N. Wilkes MD

Thomas Jefferson University Hospital

• Palpable mass/thickening

• Focal Pain

• Nipple discharge

Women under 30, targeted ultrasound is the first study, mammography as needed

Women over 30, bilateral mammogram is the first study, targeted ultrasound to follow

INDICATIONS

Symptoms

INDICATIONSAbnormal Mammogram

• Mass

• Developing asymmetry/focal asymmetry

• Architectural distortion

• Calcifications

INDICATIONSAbnormal Imaging

• MRI

• Nuclear medicine

• CAT Scan

• Contrast Enhanced Mammography (CEM)

• Other

INDICATIONSFollow up

• Probably benign masses (BIRADS 3) – 6 month f/u to assess for stability/2 year

• Abscess following antibiotic therapy

• Hematoma/seroma

• Trauma - bruise

INDICATIONSKnown or Suspected Malignancy (BIRADS 4,5,6)

• Determination of extent, multifocality

• Evaluation of axillary lymph nodes

• Monitoring response to neoadjuvant chemotherapy – breast, axilla and chest wall

• Screening chest wall lymph nodes after therapy

4/2/2021

2

INDICATIONSGuidance

• Cyst aspiration/FNA

• Pre biopsy needle localization/Savi scout placement

• Core biopsy

• Intra operative localization

• Tumor ablation

INDICATIONSImplants

• Silicone implants

MRI more sensitive for rupture

Almost entirely fat Heterogeneously dense

Extremely denseScattered

INDICATIONSDense Breasts

Whole Breast Screening Ultrasound

• Dense breasts- heterogeneously or extremely

• High risk women who cannot get an MRI

4/2/2021

3

29 yo pre neoadjuvant

Post treatment

Indication – palpable lump

palpable mass near chest wall

palpable lump – inframammary fold

4/2/2021

4

palpable lump

mass on the mammogram near the chest wall

Indication- abnormal mammogram

goes away on spot

compression?

2D Tomo

circumscribed mass

circumscribed mass

4/2/2021

5

obscured massmainly well circumscribed?

normal tissue

CXR in the ER

ductogram

4/2/2021

6

IMPLANTS

RUPTURE

INDICATION

Cyst or Solid Benign or Malignant

4/2/2021

7

the not so simple cyst

Cyst Not a Cyst

not a cyst not a cyst

4/2/2021

8

2016 2018

missed a year

Normal AnatomyTechnique

Artemis of Ephesus

Haagensens Diseases of the Breast 1986

NORMAL ANATOMY

• 15-20 LOBES

nipple - ducts – TDLU -lobule

4/2/2021

9

Homogeneous-fatty Heterogeneous Homogeneous-glandular

ducts

cooper’s ligaments skin

4/2/2021

10

Within or under the skin?

Claw signsebaceous cyst

nipple

stand off gel/pad

9 yo palp lump under nipple

Breast bud Infant breast hemangioma

4 month old with palpable massand overlying blue tint on skin

4/2/2021

11

male patient

Chest Wall Ultrasound - Inflammatory Breast Cancer

4/2/2021

12

TECHNIQUE TECHNIQUE

Real time, hand held transducer

7.5 – 18 MHZ

Dynamic focus

High resolution imaging

TECHNIQUE

Patient supine, semi-erect, sitting or on side

Ipsilateral arm above head

Shoulder elevated

TECHNIQUE

Radial

Anti-radial

Sagittal

Transverse

Label according to mammographic clock

Label distance from nipple/areolar margin

Label area of clinical concern (palpable mass, pain)

4/2/2021

13

TECHNIQUE

Focal zone

Gain

TGC

Adequate depth for far field

Gel pad for near field

Compression

Position change

cine normal breastcine cyst

cine solid masses

TECHNIQUE

Color and Spectral Doppler

Spatial Compound Imaging

Harmonic Imaging

Extended field

3D

Elastography

Contrast Enhanced Imaging

4/2/2021

14

Gain

Posterior Acoustic Features

• no enhancement

• enhancement

• shadowing

• combined pattern

Fibroadenoma

Ca

DOPPLER – absent, internal, peripheral

Confirmation solid vs. cystic

Lymph node, abscess

Pre biopsy

Vessel Characterization – contrast agents

Intraductal debris or massPapilloma

4/2/2021

15

thick walled cyst?

cyst with debris?

Intracystic Papillary Carcinoma

color and spectral Doppler

4/2/2021

16

color/power Doppler

abscesslymph node

COMPOUND IMAGING

electronic steering of transducer array allowing for multiple scanning angles

reduction of speckle, clutter and artifacts

improves detail of mass margins

calcification

posterior enhancement less apparent

HARMONIC IMAGING

transmit at one frequency, receive at multiples of that frequency

6MHz transmit/12MHz receive

reduces clutter and reverb within cysts, increases lesion conspicuity, marginal definition

good to “clean up” cysts

EXTENDED FIELD

Panoramic image

good for locating multiple masses, correlating with mammogram

implants

4/2/2021

17

Elastography – based on tissue stiffness, resistance

Ultrasound Technology-continuing work

• Artificial Intelligence ( AI)

• Whole Breast Imaging/ABUS

• Improved Lesion Detection/Characterization –vascularity-contrast, calcifications

• Computer Aided Detection

• Guidance for tumor ablation – cryotherapy

• Biopsy devices

ACR BI-RADS Breast Imaging Data and Reporting System

Tissue Composition

Homogeneous/ fat/glandular heterogeneous

4/2/2021

18

Masses - Shape

oval, round, irregular

Masses- Orientation

• parallel

• not parallel

Masses- Margin

• Circumscribed

• Not circumscribed

indistinct

angular

microlobulated

spiculated

Echo Pattern

• Anechoic

• Hyperechoic

• Complex cystic and solid

• Hypoechoic

• Isoechoic

• Heterogeneous

Calcifications

in a mass

outside of a mass

intraductal

Associated Features

• architectural distortion

• duct changes

• skin changes thickening

retraction

• edema

• vascularityabsent

internal vascularity

vessels in rim

• elastography assessmentsoft

intermediate

hard

4/2/2021

19

Special Cases

• simple cyst

• clustered microcyst

• complicated cyst

• mass in or on skin

• foreign body including implants

• lymph nodes- intramammary and axillary

• vascular abnormalities – Mondors, AVM’s

• post surgical fluid collection

• fat necrosis

Clustered Microcysts

Assessment Categories : BI-RADS

0 Incomplete

1 Negative

2 Benign

3 Probably Benign

4 Suspicious

5 Highly Suggestive of Malignancy

6 Known Biopsy Proven Cancer

Category 0 - Incomplete

• need additional imaging evaluation: additional imaging and/or prior films

Category 1: Negative

• nothing to comment on, no change, no significant findings

Category 2: Benign

also negative, but describes a characteristically benign finding such as:

• simple cyst

• intramammary lymph node

• implant problem

• stable, probable fibroadenoma

• stable post-surgical change

4/2/2021

20

Category 3 : Probably Benign

• Solid mass with circumscribed margins, oval shape, parallel (probable fibroadenoma)

• Non palpable complicated cysts, and clustered microcysts

Management of a Probably BenignMass found at Ultrasound (nonpalpable)

• If a mass is obscured >25% at mammography, or if only seen on US, then US features determine management

• If no malignant features at US, follow-up US at 6, 12, 24 mos

• 0.2% false neg rate

Category 4: Suspicious• 3-95% chance of malignancy

)

Category 4 Subdivisions

4A: lesion needing intervention with a low suspicion for malignancy ( 2-10%)

4B: moderate suspicion for malignancy (10- 50%)

4C: high suspicion for malignancy (50-95%), but not classic

Category 5: Highly Suggestive of Malignancy

• high probability of being cancer

(>95% chance of malignancy)